Corporacio Sanitaria Parc Tauli
Sabadell, Barcelona, Barcelona 08208
0 studies enrolling now · 1 studies all time
What they study most
Breast Cancer
Studies at this site
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
— Completed